Han Cao founded BioNano Genomics in 2003 as a spin out of the Princeton University laboratories where he was working on a multimillion dollar project funded by the U.S. Defense Advanced Research Projects Agency (DARPA). Dr. Cao is the key co-inventor of the company's core single-molecule nanoscale whole genome analysis technology. Prior to that, he was a postdoctoral fellow working on a stem cell and DNA repair system at the Institute for Human Gene Therapy of University of Pennsylvania Medical Center. His diverse experience includes molecular biology, microarray and genomics technology development, single-molecule analysis as well as micro and nanofluidics design and fabrication. Dr. Cao leads multiple federal government funded projects at BioNano Genomics and served on many grant review panels. He oversees the scientific and technical direction of future technology and product development at BioNano Genomics. Dr. Cao received a B.S. degree from the University of Science and Technology of China and a Ph.D. in molecular biology from the University of Delaware.